Sodium-glucose cotransporter-2 inhibitors in cancer patients with type 2 diabetes and established immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis - Poll - MDSpire

Sodium-glucose cotransporter-2 inhibitors in cancer patients with type 2 diabetes and established immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis

  • By

  • Ling Guo

  • Jing Liu

  • Ruipu Gao

  • Chunwang Yang

  • Zhenli Li

  • Zhengkun Guan

  • Yansong Wang

  • Guang Liu

  • Jingtao Ma

  • Guangbin Gao

  • April 15, 2026

  • 0 min

Share

Original Source(s)

Sodium-glucose cotransporter-2 inhibitors in cancer patients with type 2 diabetes and established immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis

  • by Ling Guo, Jing Liu, Ruipu Gao, Chunwang Yang, Zhenli Li, Zhengkun Guan, Yansong Wang, Guang Liu, Jingtao Ma, Guangbin Gao

  • April 15, 2026

Related Content

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial

Ultrasound-driven mechanical immunomodulation enhances tumor treatment sensitivity: advances from tumor mechanical immunobiology to immunotherapy applications